Unlike semaglutide (Wegovy), which targets only the GLP-1 receptor, or tirzepatide (Zepbound), which targets GLP-1 and GIP receptors, retatrutide activates three receptors simultaneously: GLP-1, GIP, and glucagon
GLP-1 Receptor Limb GLP-1R activation is the most extensively characterised pathway in this class
[9] Kumar D, Gautam N, Alnouti Y
Fantastic breakdown, Stephanie
Retatrutide dose schedule compared to tirzepatide and semaglutide Understanding how the retatrutide dose schedule differs from the two currently available GLP-1 agonists helps put the titration timeline in perspective
Microdosing GLP 1 and the Long Term Benefits for Women For many women, weight management and metabolic health become more complex with age